ARCHIVES

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

This article is from The Cancer Letter archive.

Vol. 14 No. 47 | December 2, 1988

Download PDF Visit The Full Archive

Related Articles

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012